Underwhelming28 Apr 2021 13:14
While the presentation was generally positive, I was totally underwhelmed by the lack of commercial drive to deliver shareholder value. No real answer to the funding issue raised by a couple of investors. Do we envisage some income or do we need to raise money? No real action regarding SRA 737, just the wait and see, just like the last presentation. Sierra continue to expand their applications of SRA 737, surely this constitutes further trials, how about paying up! The poster shown in todays presentation clearly showed promise to tackle several different types of cancer but we are unable to influence its progress. Who on earth negotiated this contract, some commercially inept person, that's for sure! Oh well, let's just wait until H2 for the next update.